Skip to main content Skip to section navigation Skip to footer
  • Visit us on Facebook
  • Visit us on Twitter
  • Visit us on Linkedin
Kintara Therapeutics, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaboration
    • Advisors
  • Pipeline
    • Overview
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Recent News
    • Events
  • Investors
    • Overview
    • Analyst Coverage
    • News & Events
    • Company Info
    • Stock Info
    • SEC Filings
    • Governance
  • Contact
  • Careers

Recent News

News & Media

News & Media

  • Press Releases
  • Publications and Abstracts
  • Presentations
  • Recent News
  • Events

Healio - Hem Onc Today

FDA news: Fast track for glioblastoma drug, breakthrough designation for leukemia therapy

December 28, 2022

Precision Oncology News

Kintara Therapeutics Hopes to Fill Treatment Gap in Glioblastoma With VAL-083

November 22, 2022

Cancer Therapy Advisor

Novel Agent Plus Radiotherapy Shows Promise in MGMT-Unmethylated Glioblastoma

November 19, 2022

Health Professional Radio

Kintara Therapeutics – Seeking New Horizons for Cancer Patients with Novel Therapies

November 16, 2022
rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • Page 2
©2025 Kintara Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences